Gabapentin‐induced Myoclonus in End‐stage Renal Disease

Abstract

GBP increases the risk of myoclonus in ESRD. Myoclonus in these individuals was more disabling than that in patients with normal renal function, and discontinuation of GBP is required to restore normal function.